Alzheimer’s disease is characterized by the accumulation of tau protein in the brain, which gradually damages nerve cells and impairs memory and cognitive function.
This marks the sixth visit of Mercy Ships to Madagascar since 1996, reflecting a long-term partnership aimed at strengthening surgical systems and expanding access to life-changing care.
The innovation aims to enhance fluid drainage, speed up recovery, and potentially reduce the need for additional corrective procedures.
The Noguchi Institute’s newly licensed technology focuses on controlling two critical aspects of ADC design: the drug-to-antibody ratio (DAR) and the precise attachment site of the therapeutic payload.
Researchers aim to assess the reliability of p-Tau217 in identifying early Alzheimer’s pathology and evaluate its potential as a scalable tool for long-term monitoring.
The hospital conducted the procedures in collaboration with Pentaprism Medical Africa through a skills transfer and clinical training programme designed to strengthen minimally invasive surgical care at the facility.
The procedure, carried out in Damaturu, represents the first time such an advanced maxillofacial surgery has been conducted in a state-owned hospital in the region.
The facility is built to accommodate approximately 1,000 to 1,500 healthcare professionals each year, including consultants, specialists, and early-career doctors.
The launch coincides with the company’s 30th year of operations and reinforces its strategy of building an integrated healthcare system across Uganda.
To achieve the accreditation, Fakeeh University Hospital adopted the internationally recognized “Ten Steps to Successful Breastfeeding” framework developed by WHO and UNICEF.